2022年第09期
共11篇1. Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations 651-657页
作者:Guowei ZHANGRuirui CHENGYuanyuan NIUHuijuan WANGXiangtao YANMina ZHANGXiaojuan ZHANGJinpo YANGChunhua WEIZhiyong MA